ARTICLE
Auteur(s) : Roberto
Betti1, Lorenzo Gualandri1, Raffaella
Vergani1, Silvano Menni1, Carlo
Crosti2
1Università degli Studi di Milano Clinica
Dermatologica AO San Paolo Via A. di Rudinì 8, 20142 Milan,
Italy
2Università degli Studi di Milano. Ospedale Maggiore
Policlinico, Mangiagalli e Regina Elena -Clinica Dermatologica
Fondazione IRCCS di Natura Pubblica
Synchronous melanomas are a particular subgroup of multiple
primary melanomas, (MPM), in which two or more tumours are detected
simultaneously.
We report three patients with synchronous melanomas. The first
was a 64-year-old man with two melanomas on his dorsal region (figure 1A): a
superficial spreading melanoma with incipient vertical growth Clark
level IV and 2.99 mm Breslow thickness on his left scapular
region (figure
1B) and a melanoma Clark level IV with 1.47 mm Breslow
thickness on his right dorsal lesion (figure 1C). After
lymphoscintigraphy, histological examination of the sentinel lymph
in his right armpit was negative.
The second patient was a 71-year-old bald man with a superficial
spreading melanoma, Clark level III, 0.80 mm Breslow
thickness, on the back and a lentigo maligna in situ on the
head.
The third, 71-year-old patient had a lentigo maligna melanoma in
situ on the back and a melanoma in situ on the shoulder,
respectively. About 1 year after the first, another lentigo maligna
melanoma in situ was removed from his back. The first and the
second patients had several common nevi, the first had more than
five clinically atypical nevi. No patient had a family history of
melanoma. After more than 2 years of follow up, no apparent
metastases were identified in any patient.
The frequency of MPM is probably underestimated because
case-control studies have rarely been performed [1] and follow-ups
are too brief. The estimated risk for the occurrence of a further
primary melanoma has been estimated as ranging from 8.5 [2] to
12.7% [3]. Knowledge of risk factors for patients with MPM is
important in order to perform a correct clinical follow up. Risk
factors include [2, 4]: a personal history of melanoma, genetic or
familial factors, male gender, presence of atypical and familial
nevi, younger age, a history of significant sun exposure. More than
two primary melanomas are possible, although with lower frequency.
For most patients, subsequent melanomas seem to be shallower than
the initial one [1, 4]. The localization of the second melanoma
tends to be on a site different from the initial tumour in an high
percentage of cases [1, 4]. However, a body concordance higher than
expected by chance for second melanoma was observed [5], so
suggesting a field effect of susceptibility for some anatomical
areas.
According to Johnson [4], the concurrent diagnosis of
synchronous melanomas is considered when a second melanoma is
diagnosed within one month. Interestingly, Carli et al. [6]
observed that this time represents a diagnostic delay with obvious
implications. We agree with them and think that the term
synchronous melanoma has to be applied only for melanoma diagnosed
or suspected during the same first observation.
Our three reported patients have really synchronous melanomas,
diagnosed or suspected during the same observation. In the first
patient both melanomas were in the same regional area. Patients 1
and 2 had several nevi, of which many were atypical. Patient 2
developed his second melanoma on an area totally different from the
first one.
Patient 3 developed a third melanoma in the same regional area 1
year after the first diagnosis. It is possible that frequent past
sunburns have had a late manifestation of a field effect
susceptibility.
These observations further stress the importance of a careful
examination of the whole body surface especially in the presence of
multiple common and atypical moles. Psychological factors and
lesion perception are involved in the diagnosis of melanoma. The
unconscious lowering of the physician’s alertness following the
first melanoma diagnosis may lead to disregarding the possibility
of another melanoma.
Serendipity does not apply in cases of synchronous melanomas,
but prevention does, because the chance of a further tumour is very
possible. We think that a long period of follow up is recommended
for these patients.
Acknowledgements
Financial support: none. Conflict of interest: none.
References
1 Titus-Ernstoff L, Perry AE, Spencer SK,
et al. Multiple primary melanoma. Two-year results from a
population-based study. Arch Dermatol 2006; 142: 433-8.
2 Tucker MA, Boice JD, Hoffman DA. Second cancer
following cutaneous melanoma and cancers of the brain, thyroid,
connective tissue, bone, and eye in Connecticut1935-82. NCI Monogr
1985; 68: 161-89.
3 Doubrovsky A, Menzies SW. Enhanced survival in
patients with multiple primary melanoma. Arch Dermatol 2003; 139:
1013-8.
4 Johnson TM, Hamilton T, Lowe L. Multiple
primary melanomas. J Am Acad Dermatol 1998; 39: 422-7.
5 Giles G, Staples M, McCredie M, Coates M.
Multiple primary melanomas.an analysis of cancer registry data from
Victoria and New South Wales. Melanoma Res 1995; 5: 433-8.
6 Carli P, DeGiorgi V, Chiarugi A, et al.
Multiple synchronous cutaneous melanomas: implications for
prevention. Int J Dermatol 2002; 41: 583-5.
|